Douglas Ward
Chief Executive Officer bij LUMOS DIAGNOSTICS HOLDINGS LIMITED
Vermogen: 18 905 $ op 31-03-2024
Profiel
Douglas Ward is currently the Chief Executive Officer, Director, and Managing Director at Lumos Diagnostics Holdings Ltd.
He previously served as the Chief Executive Officer at Personal Genome Diagnostics, Inc. from 2016 to 2020.
Additionally, he held the position of Vice President of Strategy and Business Development at Hologic, Inc. Mr. Ward completed his undergraduate degree at Ohio Wesleyan University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
18-10-2023 | 475 000 ( 0.10% ) | 18 905 $ | 31-03-2024 |
Actieve functies van Douglas Ward
Bedrijven | Functie | Begin |
---|---|---|
LUMOS DIAGNOSTICS HOLDINGS LIMITED | Chief Executive Officer | 21-06-2022 |
Eerdere bekende functies van Douglas Ward
Bedrijven | Functie | Einde |
---|---|---|
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Chief Executive Officer | 21-04-2020 |
HOLOGIC, INC. | Corporate Officer/Principal | - |
Opleiding van Douglas Ward
Ohio Wesleyan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HOLOGIC, INC. | Health Technology |
LUMOS DIAGNOSTICS HOLDINGS LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Personal Genome Diagnostics, Inc.
Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Health Technology |